Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
BioNTech SE (BNTX) CEO Ugur Sahin on Q2 2022 Results - Earnings Call Transcript
12:56pm, Monday, 08'th Aug 2022
BioNTech SE (NASDAQ:BNTX ) Q2 2022 Earnings Conference Call August 8, 2022 8:00 AM ET Company Participants Sylke Maas - Vice President, Investor Relations and Strategy Ugur Sahin - Chief Executive Off
BioNTech misses earnings expectations, stock falls
11:33am, Monday, 08'th Aug 2022
Yahoo Finance Live's Brad Smith discusses how BioNTech stock is trading amid earnings.
BioNTech's (BNTX) Earnings & Revenues Miss Estimates in Q2
10:33am, Monday, 08'th Aug 2022
BioNTech (BNTX) misses estimates for both earnings and revenues in the second quarter of 2022.
Why Is BioNTech (BNTX) Stock Down 7% Today?
10:07am, Monday, 08'th Aug 2022
Source: Palatinate Stock / Shutterstock.com BioNTech (NASDAQ: BNTX ) stock is on falling on Monday after the company released poor results for its second quarter of 2022. This saw it report diluted ea
BioNTech Dives As Second-Quarter Sales, Profit Broadly Miss Forecasts
09:49am, Monday, 08'th Aug 2022
BioNTech lagged second-quarter expectations and issued light 2022 guidance on Monday, leading BNTX stock to dive. The post BioNTech Dives As Second-Quarter Sales, Profit Broadly Miss Forecasts appeare
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
09:00am, Monday, 08'th Aug 2022
BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron sub variants including BA.1, BA.4 and BA.5.
BioNTech expects Omicron-adapted vaccine deliveries as soon as October
06:24am, Monday, 08'th Aug 2022
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, said the German biotech firm as it reaffirmed its vaccine re
BioNTech Earnings and Revenue Miss Expectations
06:18am, Monday, 08'th Aug 2022
The company reports second-quarter earnings of €6.45 a share on revenue of €3.2 billion.
BioNTech stock sinks more than 8% after profit, revenue fall below expectations
06:17am, Monday, 08'th Aug 2022
The U.S.-listed shares of Germany-based BioNTech SE BNTX, +1.48% sank 8.2% in premarket trading Monday, after the biotechnology company and Pfizer Inc. PFE, -1.18% partner in developing a COVID-19 vac
Is a Beat in Store for BioNTech (BNTX) This Earnings Season?
01:35pm, Tuesday, 02'nd Aug 2022
On BioNTech's (BNTX) second-quarter earnings call, investors are expected to focus on the sales performance of its COVID-19 vaccine, Comirnaty, developed in partnership with Pfizer.
Moderna And BioNTech: I Back The Former To Drive Share Price Upside In 2022
02:58pm, Friday, 29'th Jul 2022
Moderna and BioNTech are the two mRNA giants behind the dominant COVID vaccines SpikeVax and Comirnaty. The two companies have a great deal in common, and the share prices typically track very close t
Moderna 2.0: 3 Stocks To Play The Potential Monkeypox Pandemic
04:38pm, Tuesday, 26'th Jul 2022
Monkeypox cases are significantly growing during the past few months, especially catalyzed by an increase in international travel. On July 23, WHO declared the Monkeypox spread as a global health emer
BioNTech, Pfizer sue CureVac in U.S. over COVID-19 vaccine patent claims
11:59am, Tuesday, 26'th Jul 2022
COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. pate
BioNTech to Report Second Quarter 2022 Financial Results and Operational Update on August 8, 2022
06:45am, Monday, 25'th Jul 2022
Mainz, Germany, July 25, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2022 on Monday, August 8th
BioNTech and Pfizer in talks to delay Covid vaccine deliveries amid EU glut
07:36am, Tuesday, 19'th Jul 2022
BioNTech and Pfizer Inc (NYSE:PFE) are reportedly close to reaching an agreement with the European Union to extend Covid-19 vaccine deliveries until 2024, slowing deliveries amid a glut of shots in
